Racotumomab in Patients With High-risk Neuroblastoma
Clinical trial NCT02998983 · COMPLETED
Trial details
- NCT number
- NCT02998983
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2022-11-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.